Nadim Yared is a consummate networker. Indeed, the device industry entrepreneur who leads private Minneapolis-based CVRx Inc. has a lot to network about, as he stewards Barostim therapy for the treatment of chronic heart failure and hypertension onto the US and EU markets.
There, and once established, he is confident that the heart failure device (the first intended application of which was hypertension)...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?